Current status of contrast echocardiography

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Despite its many advantages, MCE is still on the threshold of clinical acceptance. One major reason is that no ultrasound contrast agent has yet been approved for myocardial opacification. The second reason is related to reimbursement, which varies from state to state and is not uniform. The third and perhaps the most important reason is lack of clinical expertise in this new modality. The instruments, imaging techniques and methods of microbubble administration are all undergoing rapid changes. In addition, the technique demands a level of commitment that is not universally present. Lack of knowledge of coronary physiology, image analysis techniques and ultrasound physics remain limitations to the widespread application of MCE. It is a matter of time, however, before these obstacles will be overcome and MCE will gain widespread acceptance. Given the accessibility of ultrasound to cardiologists the world over and the emergence of coronary artery disease as the major cause of mortality worldwide, MCE has great clinical potential.

Original languageEnglish (US)
Pages (from-to)73-75
Number of pages3
JournalACC Current Journal Review
Volume9
Issue number3
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Microbubbles
Physics
Contrast Media
Echocardiography
Coronary Artery Disease
Mortality
Cardiologists

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Nursing(all)

Cite this

Current status of contrast echocardiography. / Kaul, Sanjiv.

In: ACC Current Journal Review, Vol. 9, No. 3, 2000, p. 73-75.

Research output: Contribution to journalArticle

@article{e681641047094cda8e1eba63e18b6edb,
title = "Current status of contrast echocardiography",
abstract = "Despite its many advantages, MCE is still on the threshold of clinical acceptance. One major reason is that no ultrasound contrast agent has yet been approved for myocardial opacification. The second reason is related to reimbursement, which varies from state to state and is not uniform. The third and perhaps the most important reason is lack of clinical expertise in this new modality. The instruments, imaging techniques and methods of microbubble administration are all undergoing rapid changes. In addition, the technique demands a level of commitment that is not universally present. Lack of knowledge of coronary physiology, image analysis techniques and ultrasound physics remain limitations to the widespread application of MCE. It is a matter of time, however, before these obstacles will be overcome and MCE will gain widespread acceptance. Given the accessibility of ultrasound to cardiologists the world over and the emergence of coronary artery disease as the major cause of mortality worldwide, MCE has great clinical potential.",
author = "Sanjiv Kaul",
year = "2000",
doi = "10.1016/S1062-1458(00)00051-9",
language = "English (US)",
volume = "9",
pages = "73--75",
journal = "ACC Current Journal Review",
issn = "1062-1458",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Current status of contrast echocardiography

AU - Kaul, Sanjiv

PY - 2000

Y1 - 2000

N2 - Despite its many advantages, MCE is still on the threshold of clinical acceptance. One major reason is that no ultrasound contrast agent has yet been approved for myocardial opacification. The second reason is related to reimbursement, which varies from state to state and is not uniform. The third and perhaps the most important reason is lack of clinical expertise in this new modality. The instruments, imaging techniques and methods of microbubble administration are all undergoing rapid changes. In addition, the technique demands a level of commitment that is not universally present. Lack of knowledge of coronary physiology, image analysis techniques and ultrasound physics remain limitations to the widespread application of MCE. It is a matter of time, however, before these obstacles will be overcome and MCE will gain widespread acceptance. Given the accessibility of ultrasound to cardiologists the world over and the emergence of coronary artery disease as the major cause of mortality worldwide, MCE has great clinical potential.

AB - Despite its many advantages, MCE is still on the threshold of clinical acceptance. One major reason is that no ultrasound contrast agent has yet been approved for myocardial opacification. The second reason is related to reimbursement, which varies from state to state and is not uniform. The third and perhaps the most important reason is lack of clinical expertise in this new modality. The instruments, imaging techniques and methods of microbubble administration are all undergoing rapid changes. In addition, the technique demands a level of commitment that is not universally present. Lack of knowledge of coronary physiology, image analysis techniques and ultrasound physics remain limitations to the widespread application of MCE. It is a matter of time, however, before these obstacles will be overcome and MCE will gain widespread acceptance. Given the accessibility of ultrasound to cardiologists the world over and the emergence of coronary artery disease as the major cause of mortality worldwide, MCE has great clinical potential.

UR - http://www.scopus.com/inward/record.url?scp=0034524655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034524655&partnerID=8YFLogxK

U2 - 10.1016/S1062-1458(00)00051-9

DO - 10.1016/S1062-1458(00)00051-9

M3 - Article

AN - SCOPUS:0034524655

VL - 9

SP - 73

EP - 75

JO - ACC Current Journal Review

JF - ACC Current Journal Review

SN - 1062-1458

IS - 3

ER -